Richter Gedeon, HU0000123096

Gedeon Richter stock trades at EUR 33.67 as profit improves

Published on 09/30/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gedeon Richter stock delivered 8.7 percent constant currency revenue growth in H1 2026. Clean EBIT rose 21 percent as pharma guidance moved to double-digit growth.

Richter Gedeon, HU0000123096, Illustration mit AI erstellt.
Richter Gedeon, HU0000123096, Illustration mit AI erstellt.

Gedeon Richter stock (ISIN HU0000123096) was trading at EUR 33.67 at Lang & Schwarz on September 30, 2026 at 7:55 a.m. CEST, up 0.09 percent versus the prior close of EUR 33.64. The key earnings signal is stronger operating performance in the first half of 2026, despite foreign exchange pressure on reported figures.

Clean EBIT rises 21 percent

According to the Q2 2026 earnings call published by Yahoo Finance, constant currency revenue growth reached 8.7 percent in H1 2026, while constant currency Clean EBIT increased 21 percent. The comparison shows profitability expanding faster than revenue, an important distinction for the stock because the company is relying on operating leverage to offset currency effects.

Reported revenue stood at HUF 151.8 billion in H1 2026, representing a 3 percent increase. The gap between the constant currency and reported growth rates highlights the financial impact of foreign exchange movements during the period.

Pharma guidance moves into double digits

Management also upgraded 2026 pharma Clean EBIT guidance to double-digit growth on a constant currency basis, according to Yahoo Finance. The call linked the change to VRAYLAR performance, efficiency programs and improved profitability in the remaining businesses.

The improvement is uneven across the portfolio. Biotechnology revenue growth reached 30 percent on a constant currency basis, while women's healthcare delivered an 18.5 percent Clean EBIT margin in H1 2026. Management described that margin as exceptional for the period and said the full-year average should be lower.

Stock holds near EUR 34

For investors, the central variable is whether the faster Clean EBIT growth can continue after the first-half currency effects. Richter's reported net profit was HUF 103.5 billion in H1 2026, while foreign exchange losses exceeded HUF 32 billion in Q2, creating a clear counterweight to the operating improvement.

Gedeon Richter is listed on the Budapest Stock Exchange under ticker RICHTER. At Lang & Schwarz, the stock was trading at EUR 33.67 on September 30, 2026 at 7:55 a.m. CEST, up 0.09 percent from the EUR 33.64 prior close of September 29, 2026.

Gedeon Richter stock facts

  • Company: Gedeon Richter PLC
  • ISIN: HU0000123096
  • Ticker: RICHTER
  • Primary exchange: Budapest Stock Exchange
  • Price Lang & Schwarz (as of September 30, 2026, 7:55 a.m. CEST): EUR 33.67
  • Change versus prior close: plus 0.09 percent
  • Prior close Lang & Schwarz (September 29, 2026): EUR 33.64
  • Sector / Industry: Healthcare / Pharmaceuticals

More news and analyses on Gedeon Richter stock

Disclaimer...

en | HU0000123096 | RICHTER GEDEON | boerse | 70201849 | bgmi